HTA167 Another Hurdle in Anticancer New Drug Listing in Korea—Setting the Reimbursement Scope

Abstract

Authors

S. Kim E. Shin J. Koo

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×